877-277-7848

      MESA, AZ, Jul 25, 2012 (MARKETWIRE via COMTEX) —
      Ulthera, Inc. — a global, growth-stage medical device company
      pioneering aesthetic and medical applications using its therapeutic
      ultrasound platform technology — today announced that more than
      1,000 Ulthera Systems have been sold globally while treatments
      performed using the System have surpassed 100,000.

      In the first half of 2012, expansion into Latin America as well as
      further penetration of markets in Europe, Asia and North America
      continued to accelerate quarterly sales growth. According to Matthew
      Likens, president and CEO of Ulthera, “There has been a significant
      increase in the number of Ultherapy procedures performed this year,
      making it apparent that the word is out; both physicians and
      consumers have discovered that Ultherapy is the most consistently
      efficacious non-surgical procedure to lift and tighten skin.”

      Likens added, “Our goal as an organization is to reward those
      customers who have invested in our technology by bringing them more
      value during each year of ownership. This value will be realized
      through expanded clinical indications, elevated marketing programs,
      and ongoing product enhancements.”

      The Ulthera System is the first and only energy-based device to
      receive FDA clearance for a non-invasive aesthetic lift indication,
      and its signature procedure, Ultherapy, is a non-invasive treatment
      of the face to achieve a brow lift. The Ulthera System — which
      combines time-honored ultrasound imaging with focused ultrasound
      therapy — has been available internationally since 2008 and in the
      US since September 2009.

      About Ulthera
      Ulthera(R), Inc. is a global, growth-stage medical
      device company pioneering aesthetic and medical applications using
      its therapeutic ultrasound platform technology. The Ulthera(R) System
      is the first and only energy-based device to receive FDA clearance
      for a non-invasive aesthetic lift indication. The first application
      for Ultherapy(R) — the procedure enabled by the System — is a
      non-invasive treatment of the face to achieve a brow lift. Founded in
      2004 and based in Mesa, Ariz., Ulthera is a privately held company
      backed by top tier venture capital firms, New Enterprise Associates
      and Apposite Capital. For more information, visit
      www.ulthera.com .

      
              
              Media Contact:
              Lindsey Karberg
              Ulthera, Inc.
              480.336.1744
              Email Contact
              
              
              
      
      

      SOURCE: Ulthera

      
       
      https://www2.marketwire.com/mw/emailprcntct?id=F8E7290A82628DDF            
      
      

      Copyright 2012 Marketwire, Inc., All rights reserved.